Stock AOBI AMERICAN ORIENTAL BIOENGINEERING, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company American Oriental Bioengineering, Inc. Other OTC

Equities

AOBI

US0287315032

Pharmaceuticals

Business Summary

American Oriental Bioengineering, Inc. is an integrated pharmaceutical company. The Company is engaged in development, manufacture and commercialization of a broad range of pharmaceutical and healthcare products. The Company’s business consists of prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products. Two flagship prescription pharmaceutical products marketed in China are Shuanghuanglian Lyophilized Injection Powder, or SHL Injection Powder, and Cease Enuresis Soft Gel, or CE Gel. Over-the-counter pharmaceutical products are similar to its prescription pharmaceutical products in that they need approval from the SFDA. Its products in this category include Jinji Series, Cease Enuresis Patch (CE Patch), and Boke Series. Nutraceutical products are intended for the overall well-being. It markets several nutraceutical products in China, which include its soybean peptide based drinks, tablets, powder and instant coffee.

Sales per Business

USD in Million2011Weight2012Weight Delta
Manufacturing Revenue
67.9 %
197 92.5 % 99 67.9 % -49.94%
Distribution Revenue
32.1 %
16 7.5 % 47 32.1 % +192.87%

Sales per region

USD in Million2011Weight2012Weight Delta
China
100.0 %
213 100.0 % 145 100.0 % -31.78%

Managers

Managers TitleAgeSince
Yan Chun Li FOU
 Founder 55 -
Shujun Liu CEO
 Chief Executive Officer 71 70-11-29

Members of the board

Members of the board TitleAgeSince
Shujun Liu CEO
 Chief Executive Officer 71 70-11-29
Yan Chun Li FOU
 Founder 55 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 58,007 58,007 ( 100.00 %) 0 5.483 %
Stock B 0 1,000,000 0 0

Shareholders

NameEquities%Valuation
Columbus Circle Investors
0.1438 %
105 0.1438 % 0 $
Citizens Advisers, Inc.
0.0616 %
45 0.0616 % 0 $
Pensionskassernes Administration A/S
0.0288 %
21 0.0288 % 0 $
Hundredfold Advisors LLC
0.009589 %
7 0.009589 % 0 $
Trusco Capital Management, Inc.
0.006849 %
5 0.006849 % 0 $
Security Kapitalanlage AG
0.004110 %
3 0.004110 % 0 $
MAK Allen & Day Capital Partners, Inc.
0.001370 %
1 0.001370 % 0 $
Research Affiliates LLC
0.001370 %
1 0.001370 % 0 $
AlphaStream Portfolios, Inc.
0.001370 %
1 0.001370 % 0 $
Highstreet Asset Management, Inc.
0.000000 %
0 0.000000 % - $

Company contact information

American Oriental Bioengineering, Inc.

1 Liangshuihe First Avenue Beijing E-Town Economic Zone

100176, Beijing

+86 10 5982 2039

http://www.bioaobo.com
address American Oriental Bioengineering, Inc.(AOBI)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.88% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.29% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.38% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.07% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.74% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.79% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 196B
AMGEN INC. Stock Amgen Inc.
-4.79% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AOBI Stock
  4. AOBI Stock
  5. Company American Oriental Bioengineering, Inc.